Compare EWBC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EWBC | HOLX |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 16.6B |
| IPO Year | 1999 | 1990 |
| Metric | EWBC | HOLX |
|---|---|---|
| Price | $114.13 | $74.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $126.62 | $77.89 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 01-22-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 9.52 | 2.40 |
| Revenue | $2,697,061,000.00 | ★ $4,126,500,000.00 |
| Revenue This Year | $8.30 | $6.74 |
| Revenue Next Year | $3.94 | $5.48 |
| P/E Ratio | ★ $12.02 | $31.18 |
| Revenue Growth | ★ 13.05 | 2.17 |
| 52 Week Low | $68.27 | $51.90 |
| 52 Week High | $119.73 | $75.36 |
| Indicator | EWBC | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 49.09 |
| Support Level | $110.76 | $72.28 |
| Resistance Level | $116.07 | $75.36 |
| Average True Range (ATR) | 2.80 | 0.41 |
| MACD | -0.31 | -0.03 |
| Stochastic Oscillator | 53.39 | 84.42 |
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.